<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>International Journal of Molecular and Cellular Medicine</title>
<title_fa>مجله بین المللی سلولی و مولکولی</title_fa>
<short_title>Int J Mol Cell Med</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijmcmed.org</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2251-9637</journal_id_issn>
<journal_id_issn_online>2251-9645</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.22088/IJMCM.BUMS</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1404</year>
	<month>4</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2025</year>
	<month>7</month>
	<day>1</day>
</pubdate>
<volume>14</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Dose-Dependent Modulation of NMDA Receptors: Neuroprotective Mechanisms Against Oxidative Stress in Hippocampal Neurons</title>
	<subject_fa>Neurosciences</subject_fa>
	<subject>Neurosciences</subject>
	<content_type_fa>Original Article</content_type_fa>
	<content_type>Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;text-justify:kashida&quot;&gt;&lt;span style=&quot;text-kashida:0%&quot;&gt;&lt;span style=&quot;line-height:14.0pt&quot;&gt;&lt;span style=&quot;text-autospace:none&quot;&gt;&lt;span style=&quot;font-family:Calibri,sans-serif&quot;&gt;&lt;span style=&quot;font-size:12px;&quot;&gt;&lt;span style=&quot;font-family:Tahoma;&quot;&gt;&lt;span lang=&quot;EN-CA&quot;&gt;N-Methyl-D-Aspartate (NMDA) receptors are involved in synaptic plasticity and neuronal communication. They have various responses to oxidative stress based on the dosage of agonists or antagonists that may be applied. This study focuses on modulation of NMDA receptors in primary hippocampal neurons in oxidative stress condition to understand the effects of NMDA receptor activation and inhibition. In our experiments, primary hippocampal neurons were treated with NMDA and MK-801 to assess their effect on cell viability and apoptosis. Oxidative stress was induced at different concentrations, to evaluate NMDA receptor activity and the neuroprotective effects of MK-801. Apoptosis rates were specified by applying flow cytometry, and assaying caspase-3 activity. Intracellular calcium levels were monitored using fluorescent dye Fura-2 AM. &lt;/span&gt;&lt;span lang=&quot;EN-ID&quot;&gt;NMDA at 200 &amp;mu;M significantly prevented the cytotoxic effect induced by &lt;/span&gt;&lt;span lang=&quot;EN-CA&quot;&gt;H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2 &lt;/sub&gt;&lt;/span&gt;&lt;span lang=&quot;EN-ID&quot;&gt;(P&lt;0.001). MK-801 with concentrations of 5 to 20 &amp;mu;M, could reverse the cytotoxic effect of &lt;/span&gt;&lt;span lang=&quot;EN-CA&quot;&gt;H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2&lt;/sub&gt;&lt;/span&gt;&lt;span lang=&quot;EN-ID&quot;&gt;. As a result, it significantly inhibited the toxicity of &lt;/span&gt;&lt;span lang=&quot;EN-CA&quot;&gt;H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2 &lt;/sub&gt;&lt;/span&gt;&lt;span lang=&quot;EN-ID&quot;&gt;on neuronal cells (P&lt;0.001), while 40 &amp;mu;M could not reverse its effects.&amp;nbsp; &lt;/span&gt;&lt;span lang=&quot;EN-CA&quot;&gt;NMDA (200 &amp;mu;M) increased neuronal survival to 88.3% in the presence of H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2&lt;/sub&gt; and prevented apoptosis. MK-801 (5 &amp;mu;M) also elevated cell survival to 87.2%. Treatment with NMDA (200 &amp;micro;M) + H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2 &lt;/sub&gt;also did not show any changes in the Fura-2AM fluorescence compared to the H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2 &lt;/sub&gt;group (P&gt;0.05). However, MK-801+ H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2 &lt;/sub&gt;reduced the effects of H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2 &lt;/sub&gt;on the fluorescence ratio and calcium influx considerably in comparison with the H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2 &lt;/sub&gt;group (P&lt;0.01)&lt;/span&gt;&lt;span dir=&quot;RTL&quot; lang=&quot;AR-SA&quot;&gt;.&lt;/span&gt; Treatment with MK-801 (5 &amp;mu;M) effectively mitigated the effects of &lt;span lang=&quot;EN-CA&quot;&gt;H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2&lt;/sub&gt; on caspase-3 activity compared to the H&lt;sub&gt;2&lt;/sub&gt;O&lt;sub&gt;2 &lt;/sub&gt;group (P&lt;0.001).&lt;/span&gt; &lt;/span&gt;&lt;/span&gt;&lt;span lang=&quot;EN-CA&quot; style=&quot;font-size:10.0pt&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;span style=&quot;font-size:12px;&quot;&gt;&lt;span style=&quot;font-family:Tahoma;&quot;&gt;Importantly, the dose-dependent effects of NMDA receptors offer a new path into finding therapeutic strategies for neurodegenerative diseases&lt;/span&gt;&lt;/span&gt;&lt;b&gt;&lt;i&gt;&lt;span style=&quot;font-size:12px;&quot;&gt;&lt;span style=&quot;font-family:Tahoma;&quot;&gt;.&lt;/span&gt;&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;b&gt;&lt;i&gt;&lt;span lang=&quot;EN-ID&quot; style=&quot;font-size:10.0pt&quot;&gt;&lt;span style=&quot;font-family:&quot;Times New Roman&quot;,serif&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>NMDA receptors, Oxidative stress, Hippocampal neurons, Neuroprotection, apoptosis</keyword>
	<start_page>682</start_page>
	<end_page>693</end_page>
	<web_url>http://ijmcmed.org/browse.php?a_code=A-10-8203-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Marjan</first_name>
	<middle_name></middle_name>
	<last_name>Nikbakhtzadeh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>nikbakhtzadeh@gmail.com</email>
	<code>100319475328460034461</code>
	<orcid>100319475328460034461</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Physiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Asal</first_name>
	<middle_name></middle_name>
	<last_name>Behboodian</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>behboudianasal@gmail.com</email>
	<code>100319475328460034462</code>
	<orcid>0009-0007-4353-5020</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Pharmacology and Toxicology, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Maryam</first_name>
	<middle_name></middle_name>
	<last_name>Mohammadnia</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>maryamf1378@gmail.com</email>
	<code>100319475328460034463</code>
	<orcid>0009-0005-0726-6164</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Zahra</first_name>
	<middle_name></middle_name>
	<last_name>Yaghoobi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>zyaghoobi89@gmail.com</email>
	<code>100319475328460034464</code>
	<orcid>100319475328460034464</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Division of Neurobiology, Faculty of Biology, Ludwig-Maximilians-Universität München, München, Germany</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Saereh</first_name>
	<middle_name></middle_name>
	<last_name>Hosseindoost</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>saereh.hoseindoost@gmail.com</email>
	<code>100319475328460034465</code>
	<orcid>100319475328460034465</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Pain Research Center, Neuroscience Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Afshin</first_name>
	<middle_name></middle_name>
	<last_name>Kheradmand</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>kheradmand.a@iums.ac.ir</email>
	<code>100319475328460034466</code>
	<orcid>0009-0009-4088-5601</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ghorbangol</first_name>
	<middle_name></middle_name>
	<last_name>Ashabi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>gh-ashabi@tums.ac.ir</email>
	<code>100319475328460034467</code>
	<orcid>100319475328460034467</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Physiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
